Skip NavigationSkip to Content
Return Return to Search Results

TRPC Channels and Glioma

  1. Author:
    Li, Shanshan
    Ding, Xia

  2. Author Address

    Department of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza, Houston, 77030, TX, USA. shanshan.li@bcm.edu., Mouse Cancer Genetics Program, National Cancer Institute, NIH, Frederick, MD, 21702, USA. xia.ding@nih.gov.,
    1. Year: 2017
  2. Journal: Advances in Experimental Medicine and Biology
    1. 976
    2. Pages: 157-165
  4. Type of Article: Article
  5. Article Number: 157-165
  1. Abstract:

    Glioma is the most common type of brain tumors and malignant glioma is extremely lethal, with patients 39; 5-year survival rate less than 10%. Treatment of gliomas poses remarkable clinical challenges, not only because of their particular localization but also because glioma cells possess several malignant biological features, including highly proliferative, highly invasive, highly angiogenic, and highly metabolic aberrant. All these features make gliomas highly recurrent and drug resistant. Finding new and effective molecular drug targets for glioma is an urgent and critical task for both basic and clinical research. Recent studies have proposed a type of non-voltage-gated calcium channels, namely, canonical transient receptor potential (TRPC) channels, to be newly emerged potential drug targets for glioma. They are heavily involved in the proliferation, migration, invasion, angiogenesis, and metabolism of glioma cells. Abundant evidence from both cell models and preclinical mouse models has demonstrated that inhibition of TRPC channels shows promising anti-glioma effect. In this chapter, we will give a comprehensive review on the current progress in the studies on TRPC channels and glioma and discuss their potential clinical implication in glioma therapy.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1007/978-94-024-1088-4_14
  3. PMID: 28508321

Library Notes

  1. Fiscal Year: FY2016-2017
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel